Urological cancer: walking the tightrope of survival and quality of life with ADT.

作者信息

Resnick Matthew J

机构信息

Department of Urologic Surgery, Vanderbilt University Medical Center and the Tennessee Valley Veterans Affairs Health Care System, 2525 West End Avenue, Suite 1200, Nashville, TN 37203, USA.

出版信息

Nat Rev Clin Oncol. 2013 Jun;10(6):307-8. doi: 10.1038/nrclinonc.2013.78. Epub 2013 May 7.

DOI:10.1038/nrclinonc.2013.78

PMID:23648827

Abstract

摘要

相似文献

[1]

Urological cancer: walking the tightrope of survival and quality of life with ADT.

Nat Rev Clin Oncol. 2013-6

[2]

[Prostate cancer - androgen deprivation: intermittent or continuous?].

Aktuelle Urol. 2014-5

[3]

Re: Intermittent versus continuous androgen deprivation in prostate cancer.

J Urol. 2013-12

[4]

Words of wisdom. Re: Intermittent versus continuous androgen deprivation in prostate cancer.

Eur Urol. 2013-12

[5]

Androgen-deprivation therapy in men with metastatic prostate cancer: less may not necessarily be more.

Asian J Androl. 2013-7

[6]

Intermittent versus continuous androgen deprivation in prostate cancer.

N Engl J Med. 2013-4-4

[7]

Commentary on "Intermittent versus continuous androgen deprivation in prostate cancer." Hussain M, Tangen CM, Berry DL, Higano CS, Crawford ED, Liu G, Wilding G, Prescott S, Kanaga Sundaram S, Small EJ, Dawson NA, Donnelly BJ, Venner PM, Vaishampayan UN, Schellhammer PF, Quinn DI, Raghavan D, Ely B, Moinpour CM, Vogelzang NJ, Thompson IM Jr, University of Michigan, Division of Hematology/Oncology, Ann Arbor, MI. N Engl J Med 2013; 368(14):1314-25. doi: 10.1056/NEJMoa1212299.

Urol Oncol. 2014-8

[8]

Commentary on "Intermittent versus continuous androgen deprivation in prostate cancer." Hussain M, Tangen CM, Berry DL, Higano CS, Crawford ED, Liu G, Wilding G, Prescott S, Kanaga Sundaram S, Small EJ, Dawson NA, Donnelly BJ, Venner PM, Vaishampayan UN, Schellhammer PF, Quinn DI, Raghavan D, Ely B, Moinpour CM, Vogelzang NJ, Thompson IM Jr., University of Michigan, Division of Hematology/Oncology, 1500 E Medical Center Dr., 7314 CC, Ann Arbor, MI. N Engl J Med 2013;368(14):1314-25.

Urol Oncol. 2013-11

[9]

Safe usage of bicalutamide and goserelin in a male patient with acute intermittent porphyria and prostate cancer.

Scand J Urol. 2019

[10]

Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide.

BJU Int. 2012-4-13

引用本文的文献

[1]

Current Clinical Aspects of Androgen Deprivation Therapy for Locally Advanced and Metastatic Prostate Cancer: A Scoping Review for Urologists and Medical Providers.

Res Rep Urol. 2024-9-16

[2]

Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the Details.

J Clin Oncol. 2016-1-20

本文引用的文献

[1]

Intermittent versus continuous androgen deprivation in prostate cancer.

N Engl J Med. 2013-4-4

[2]

Intermittent androgen suppression for rising PSA level after radiotherapy.

N Engl J Med. 2012-9-6

[3]

Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry.

Cancer. 2011-3-15

[4]

Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer.

J Clin Oncol. 2010-11-1

[5]

Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.

Eur Urol. 2009-6

[6]

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Med Care. 2003-5

[7]

Minimum important difference between patients with rheumatoid arthritis: the patient's perspective.

J Rheumatol. 1993-3

[8]

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

J Clin Epidemiol. 1994-1

[9]

Measurement of health status. Ascertaining the minimal clinically important difference.

Control Clin Trials. 1989-12

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Urological cancer: walking the tightrope of survival and quality of life with ADT.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献